Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 201-210 of 2856 for cancer

Edit search filters
  1. Pafolacianine For Localization Of Pediatric Extracranial Solid Tumors

    Rochester, MN

  2. An Investigational Immuno-therapy Study Of Nivolumab, Compared To Placebo, In Patients With Bladder Or Upper Urinary Tract Cancer, Following Surgery To Remove The Cancer

    Rochester, MN

  3. A Clinical Study Of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) In People With Breast Cancer (MK-2870-032)

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  4. Diet in Altering Disease Progression in Patients with Prostate Cancer on Active Surveillance

    Rochester, MN

  5. Pembrolizumab With Chemotherapy And With/Without MK-4830 For Treating Participants With Ovarian Cancer

    Jacksonville, FL

  6. A Study Of Single Patient Investigational Drug CPI-613 For Use In Treatment-Refractory, Metastatic Prostate Cancer

    Rochester, MN

  7. A Study To Evaluate Durvalumab Plus Topotecan Or Lurbinectedin In Patients With Small Cell Lung Cancer

    Rochester, MN

  8. Study Of CG0070 Given In Combination With Pembrolizumab, In Non Muscle Invasive Bladder Cancer, Unresponsive To Bacillus Calmette-Guerin

    Rochester, MN

  9. A Comparison Of TULSA Procedure Vs. Radical Prostatectomy In Participants With Localized Prostate Cancer (CAPTAIN)

    Jacksonville, FL, Rochester, MN

  10. A Study To Evaluate Gemcitabine In Patients Undergoing Radical Nephroureterectomy For Upper Tract Urothelial Carcinoma

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer